3-chlorocarpipramine has been researched along with Chronic Disease in 2 studies
3-chlorocarpipramine: RN given refers to parent cpd; structure
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamagami, S | 2 |
| Kiriike, N | 1 |
| Kawaguchi, K | 1 |
2 trials available for 3-chlorocarpipramine and Chronic Disease
| Article | Year |
|---|---|
A single-blind study of clocapramine and sulpiride in hospitalized chronic schizophrenic patients.
Topics: Adult; Chronic Disease; Dibenzazepines; Female; Humans; Male; Middle Aged; Psychiatric Status Rating | 1988 |
A crossover study of clocapramine and haloperidol in chronic schizophrenia.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Basal Ganglia Diseases; Chronic Disease; D | 1985 |